These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27702835)

  • 1. Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.
    Li HW; Wong BP; Ip WK; Yeung WS; Ho PC; Ng EH
    Hum Reprod; 2016 Dec; 31(12):2796-2802. PubMed ID: 27702835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay.
    Welsh P; Smith K; Nelson SM
    Hum Reprod; 2014 May; 29(5):1035-41. PubMed ID: 24578473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay.
    van Helden J; Weiskirchen R
    Hum Reprod; 2015 Aug; 30(8):1918-26. PubMed ID: 26093541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay.
    Han X; McShane M; Sahertian R; White C; Ledger W
    Hum Reprod; 2014 May; 29(5):1042-8. PubMed ID: 24626805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing.
    Iliodromiti S; Salje B; Dewailly D; Fairburn C; Fanchin R; Fleming R; Li HWR; Lukaszuk K; Ng EHY; Pigny P; Tadros T; van Helden J; Weiskirchen R; Nelson SM
    Hum Reprod; 2017 Aug; 32(8):1710-1715. PubMed ID: 28854583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.
    Rustamov O; Smith A; Roberts SA; Yates AP; Fitzgerald C; Krishnan M; Nardo LG; Pemberton PW
    Hum Reprod; 2012 Oct; 27(10):3085-91. PubMed ID: 22777530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays.
    Nelson SM; Pastuszek E; Kloss G; Malinowska I; Liss J; Lukaszuk A; Plociennik L; Lukaszuk K
    Fertil Steril; 2015 Oct; 104(4):1016-1021.e6. PubMed ID: 26183313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Access AMH assay as an automated, high-performance replacement for the AMH Generation II manual ELISA.
    Pearson K; Long M; Prasad J; Wu YY; Bonifacio M
    Reprod Biol Endocrinol; 2016 Feb; 14():8. PubMed ID: 26879773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II).
    Wallace AM; Faye SA; Fleming R; Nelson SM
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):370-3. PubMed ID: 21628625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination.
    Anckaert E; Öktem M; Thies A; Cohen-Bacrie M; Daan NM; Schiettecatte J; Müller C; Topcu D; Gröning A; Ternaux F; Engel C; Engelmann S; Milczynski C
    Clin Biochem; 2016 Feb; 49(3):260-7. PubMed ID: 26500002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone measurement.
    Craciunas L; Roberts SA; Yates AP; Smith A; Fitzgerald C; Pemberton PW
    Fertil Steril; 2015 Feb; 103(2):554-59.e1. PubMed ID: 25487749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First fully automated immunoassay for anti-Müllerian hormone.
    Gassner D; Jung R
    Clin Chem Lab Med; 2014 Aug; 52(8):1143-52. PubMed ID: 24622790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
    Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance characteristics of the Access AMH assay for the quantitative determination of anti-Müllerian hormone (AMH) levels on the Access* family of automated immunoassay systems.
    Demirdjian G; Bord S; Lejeune C; Masica R; Rivière D; Nicouleau L; Denizot P; Marquet PY
    Clin Biochem; 2016 Nov; 49(16-17):1267-1273. PubMed ID: 27542330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related Curves of AMH Using the Gen II, the picoAMH, and the Elecsys Assays in Women With Polycystic Ovary Syndrome.
    Barbagallo F; van der Ham K; Willemsen SP; Louwers YV; Laven JS
    J Clin Endocrinol Metab; 2024 Sep; 109(10):2561-2570. PubMed ID: 38486510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of different anti-Müllerian hormone - AMH assays for the purpose of pregnancy prediction.
    Liss J; Kunicki M; Czyzyk A; Pastuszek E; Zabielska J; Meczekalski B; Lukaszuk K
    Gynecol Endocrinol; 2017 Oct; 33(10):791-796. PubMed ID: 28447513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between AMH assays differs depending on actual AMH levels.
    Magnusson Å; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod Open; 2017; 2017(4):hox026. PubMed ID: 30895238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.